These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32376860)

  • 1. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi.
    Swarthout TD; Fronterre C; Lourenço J; Obolski U; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; Diggle P; French N; Heyderman RS
    Nat Commun; 2020 May; 11(1):2222. PubMed ID: 32376860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
    Heinsbroek E; Tafatatha T; Phiri A; Swarthout TD; Alaerts M; Crampin AC; Chisambo C; Mwiba O; Read JM; French N
    Vaccine; 2018 Nov; 36(48):7369-7376. PubMed ID: 30352744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
    Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
    McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
    Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studies.
    Bar-Zeev N; Swarthout TD; Everett DB; Alaerts M; Msefula J; Brown C; Bilima S; Mallewa J; King C; von Gottberg A; Verani JR; Whitney CG; Mwansambo C; Gordon SB; Cunliffe NA; French N; Heyderman RS;
    Lancet Glob Health; 2021 Jul; 9(7):e989-e998. PubMed ID: 34143997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
    Lindstrand A; Kalyango J; Alfvén T; Darenberg J; Kadobera D; Bwanga F; Peterson S; Henriques-Normark B; Källander K
    PLoS One; 2016; 11(11):e0166018. PubMed ID: 27829063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
    Isturiz R; Sings HL; Hilton B; Arguedas A; Reinert RR; Jodar L
    Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.
    Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L
    Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study.
    Lourenço J; Obolski U; Swarthout TD; Gori A; Bar-Zeev N; Everett D; Kamng'ona AW; Mwalukomo TS; Mataya AA; Mwansambo C; Banda M; Gupta S; French N; Heyderman RS
    BMC Med; 2019 Dec; 17(1):219. PubMed ID: 31801542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
    Dagan R
    Expert Rev Vaccines; 2019 Jun; 18(6):641-661. PubMed ID: 31230486
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
    Vaccine; 2017 Feb; 35(6):945-950. PubMed ID: 28087146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
    Verani JR; Massora S; Acácio S; Dos Santos RT; Vubil D; Pimenta F; Moura I; Whitney CG; Costa MH; Macete E; Matsinhe MB; Carvalho MDG; Sigaúque B
    PLoS One; 2018; 13(2):e0191113. PubMed ID: 29447196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
    Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
    Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pragmatic health centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+0 to 2+1 in a high pneumococcal carriage and disease burden setting in Malawi: a study protocol.
    Swarthout TD; Ibarz-Pavon A; Kawalazira G; Sinjani G; Chirombo J; Gori A; Chalusa P; Bonomali F; Nyirenda R; Bulla E; Brown C; Msefula J; Banda M; Kachala J; Mwansambo C; Henrion MY; Gordon SB; French N; Heyderman RS
    BMJ Open; 2021 Jun; 11(6):e050312. PubMed ID: 34140345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.
    Sime WT; Aseffa A; Woldeamanuel Y; Brovall S; Morfeldt E; Henriques-Normark B
    BMC Infect Dis; 2019 May; 19(1):409. PubMed ID: 31077141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.